Impact of early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with acute coronary syndrome: A systematic review meta-analysis

CONCLUSION: PCSK9i are highly effective in early reduction of LDL-C along with reduction of early hospital readmissions post-ACS.PMID:37777180 | DOI:10.1016/j.ihj.2023.09.005

Source: Indian Heart J - September 30, 2023 Category: Cardiology Authors: Lakshmi Nagendra Kunal Mahajan Gunjan Gupta Deep Dutta Source Type: research